Thalia Erbes

1.4k total citations
49 papers, 907 citations indexed

About

Thalia Erbes is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Thalia Erbes has authored 49 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Thalia Erbes's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (13 papers) and Breast Cancer Treatment Studies (9 papers). Thalia Erbes is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (13 papers) and Breast Cancer Treatment Studies (9 papers). Thalia Erbes collaborates with scholars based in Germany, United States and Netherlands. Thalia Erbes's co-authors include Elmar Stickeler, Marc Hirschfeld, Sebastian Mayer, G. Gitsch, Gerta Rücker, Markus Jaeger, Bernd Kammerer, Daniela Weiß, Séverine Iborra and Markus Jäger and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Thalia Erbes

47 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thalia Erbes Germany 19 527 430 234 113 76 49 907
Natalie I. Vokes United States 12 714 1.4× 501 1.2× 228 1.0× 48 0.4× 203 2.7× 46 1.1k
Katharina Malinowsky Germany 17 389 0.7× 177 0.4× 149 0.6× 124 1.1× 73 1.0× 27 660
Vilde Drageset Haakensen Norway 21 761 1.4× 314 0.7× 330 1.4× 86 0.8× 154 2.0× 42 1.1k
Xiaoguang Sun China 13 351 0.7× 317 0.7× 167 0.7× 118 1.0× 117 1.5× 19 756
Mylan Pho United States 7 690 1.3× 716 1.7× 449 1.9× 75 0.7× 146 1.9× 9 1.4k
Danian Dai China 15 448 0.9× 398 0.9× 295 1.3× 58 0.5× 169 2.2× 28 823
Weiguo Wu United States 16 601 1.1× 152 0.4× 314 1.3× 66 0.6× 99 1.3× 33 978
Anne‐Sofie Schrohl Denmark 14 276 0.5× 358 0.8× 382 1.6× 47 0.4× 84 1.1× 21 715
Karla Esbona United States 13 327 0.6× 228 0.5× 238 1.0× 83 0.7× 67 0.9× 20 797
David James VanderWeele United States 15 485 0.9× 262 0.6× 300 1.3× 90 0.8× 355 4.7× 57 1.0k

Countries citing papers authored by Thalia Erbes

Since Specialization
Citations

This map shows the geographic impact of Thalia Erbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thalia Erbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thalia Erbes more than expected).

Fields of papers citing papers by Thalia Erbes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thalia Erbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thalia Erbes. The network helps show where Thalia Erbes may publish in the future.

Co-authorship network of co-authors of Thalia Erbes

This figure shows the co-authorship network connecting the top 25 collaborators of Thalia Erbes. A scholar is included among the top collaborators of Thalia Erbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thalia Erbes. Thalia Erbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ge, Isabell, Benjamin Schmidt, Markus Jäger, et al.. (2025). Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?. Experimental and Therapeutic Medicine. 29(3). 54–54.
2.
Ge, Isabell, et al.. (2024). Real-World Data Analysis of CDK4/6 Inhibitor Therapy—A Patient-Centric Single Center Study. Cancers. 16(9). 1760–1760. 3 indexed citations
3.
Ge, Isabell, Thalia Erbes, & Ingolf Juhasz‐Böss. (2022). Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature. Archives of Gynecology and Obstetrics. 306(4). 943–957. 11 indexed citations
4.
Metzger, Patrick, Martin L. Biniossek, Klemens Fröhlich, et al.. (2022). Krüppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer. Breast Cancer Research. 24(1). 65–65. 8 indexed citations
5.
Hirschfeld, Marc, Gerta Rücker, Markus Jäger, et al.. (2021). Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro. Breast Cancer Targets and Therapy. Volume 13. 659–673. 5 indexed citations
6.
Hirschfeld, Marc, Daniela Weiß, Gerta Rücker, et al.. (2021). Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study. Archives of Gynecology and Obstetrics. 306(1). 151–163. 7 indexed citations
7.
Donkers, Hannah, Marc Hirschfeld, Daniela Weiß, et al.. (2021). Usefulness of microRNA detection in the diagnostics of endometrial cancer. Acta Obstetricia Et Gynecologica Scandinavica. 100(6). 1148–1154. 12 indexed citations
8.
Donkers, Hannah, Marc Hirschfeld, Daniela Weiß, et al.. (2021). Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study. International Journal of Gynecological Cancer. 31(6). 868–874. 10 indexed citations
9.
Hirschfeld, Marc, Isabell Ge, Sebastian Mayer, et al.. (2020). Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in�vitro. Molecular Medicine Reports. 22(5). 4048–4060. 9 indexed citations
10.
Hirschfeld, Marc, Gerta Rücker, Daniela Weiß, et al.. (2020). Urinary exosomal microRNAs as potential non-invasive biomarkers in breast cancer detection. Geburtshilfe und Frauenheilkunde. 1 indexed citations
11.
Eismann, Julia, Marc Hirschfeld, Thalia Erbes, et al.. (2017). Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro. Oncology Reports. 38(2). 993–1004. 17 indexed citations
12.
Erbes, Thalia, Elmar Stickeler, Gerta Rücker, et al.. (2016). BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-Analysis. Clinical Breast Cancer. 16(4). e119–e132. 24 indexed citations
13.
Aumann, Konrad, Ulrich F. Wellner, Peter Bronsert, et al.. (2016). Structured reporting ensures complete content and quick detection of essential data in pathology reports of oncological breast resection specimens. Breast Cancer Research and Treatment. 156(3). 495–500. 22 indexed citations
14.
Stoykow, C., Thalia Erbes, Helmut R. Maëcke, et al.. (2016). Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET. Theranostics. 6(10). 1641–1650. 96 indexed citations
15.
Mayer, Sebastian, Marc Hirschfeld, Markus Jaeger, et al.. (2015). RON alternative splicing regulation in primary ovarian cancer. Oncology Reports. 34(1). 423–430. 21 indexed citations
16.
Hirschfeld, Marc, Yi Ouyang, Markus Jaeger, et al.. (2015). HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer. BMC Cancer. 15(1). 86–86. 25 indexed citations
17.
Erbes, Thalia, Sebastian Halbach, Tilman Brummer, et al.. (2015). Exometabolom analysis of breast cancer cell lines: Metabolic signature. Scientific Reports. 5(1). 13374–13374. 26 indexed citations
18.
Farthmann, Juliane, Dirk Watermann, Thalia Erbes, et al.. (2014). Functional outcome after pelvic floor reconstructive surgery with or without concomitant hysterectomy. Archives of Gynecology and Obstetrics. 291(3). 573–577. 21 indexed citations
19.
Erbes, Thalia, Marzenna Orlowska‐Volk, Axel zur Hausen, et al.. (2014). Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection. BMC Cancer. 14(1). 4–4. 23 indexed citations
20.
Hirschfeld, Marc, Bo Zhang, Markus Jaeger, et al.. (2013). Hypoxia‐dependent mRNA expression pattern of splicing factor YT521 and its impact on oncological important target gene expression. Molecular Carcinogenesis. 53(11). 883–892. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie I. Vokes Breakdown of academic impact, for papers by Katharina Malinowsky Breakdown of academic impact, for papers by Vilde Drageset Haakensen Breakdown of academic impact, for papers by Xiaoguang Sun Breakdown of academic impact, for papers by Mylan Pho Breakdown of academic impact, for papers by Danian Dai Breakdown of academic impact, for papers by Weiguo Wu Breakdown of academic impact, for papers by Anne‐Sofie Schrohl Breakdown of academic impact, for papers by Karla Esbona Breakdown of academic impact, for papers by David James VanderWeele
Rankless by CCL
2026